CX Venture Group is a venture capital and private equity firm investing in technology and biotechnology companies that is headquartered in Taipei, Taiwan and was founded in 1990. The firm is no longer operating.
As of December 2019, CX Venture Group made one investment in Cellerant Therapeutics (series B) on May 11, 2005 alongside Novel Bioventures, MPM Capital, Allen & Company LLC, and George Rathmann. The investment in Cellerant Therapeutics was worth a total of $16 million from all investors.
Documentaries, videos and podcasts